Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-dose Prophylactic INdomethacin in Extremely Preterm Infants - A Multicenter Randomized Blinded Placebo-Controlled Trial (the SPIN RCT)

NCT06572917 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06572917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06572917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-dose Prophylactic INdomethacin in Extremely Preterm Infants - A Multicenter Randomized Blinded Placebo-Controlled Trial (the SPIN RCT)
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2025
Completion date
March 31, 2031
Enrollment
500 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

extreme prematurity, intraventricular hemorrhage, morbidity;newborn